Mahmoud Aloui

Title: Mahmoud Aloui: Innovator in Pharmaceutical Chemistry

Introduction

Mahmoud Aloui is a notable inventor based in Hitchin, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of cabergoline, a medication used to treat various medical conditions.

Latest Patents

Aloui holds a patent for the "Preparation of cabergoline." This patent describes a method of preparing cabergoline Form I, which involves forming a solvate that includes cabergoline and a p-disubstituted benzene or 1,3,5-trimethylbenzene. The process allows for the recovery of cabergoline Form I through direct crystallization or by converting a solvate into Form I. Additionally, the patent introduces a novel cabergoline polymorph designated as cabergoline Form F, which can be prepared by dissolving cabergoline in fluorobenzene.

Career Highlights

Mahmoud Aloui is associated with Resolution Chemicals Limited, where he applies his expertise in pharmaceutical development. His work has led to advancements in the formulation and preparation of important pharmaceutical compounds.

Collaborations

Aloui collaborates with talented coworkers, including Parveen Bhatarah and Derek McHattie, contributing to a dynamic research environment that fosters innovation.

Conclusion

Mahmoud Aloui's contributions to the field of pharmaceutical chemistry, particularly through his patent on cabergoline, highlight his role as an innovator in the industry. His work continues to impact the development of effective medications.